The state of Pennsylvania, specifically Lancaster County, is attracting major pharmaceutical investments from companies like GSK and Eli Lilly.
Steady: 0 in the last 7 days
Updated sep 4
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The state of Pennsylvania, specifically Lancaster County, is attracting major pharmaceutical investments from companies like GSK and Eli Lilly.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.Sub-event
Pennsylvania and Lancaster County are attracting pharmaceutical investments from GSK and Eli Lilly.1 source
Keep exploring
The entities involved
-
Pennsylvania
state of the United States of America
-
Lancaster County
county in Pennsylvania, United States
-
GlaxoSmithKline
company in Tokyo, Japan
Nothing else this week.
-
Eli Lilly and Company
American pharmaceutical company